CELLECTIS S A's ticker is CLLS and the CUSIP is 15117K103. A total of 79 filers reported holding CELLECTIS S A in Q2 2021. The put-call ratio across all filers is 1.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,037,428 | -21.1% | 656,600 | -1.6% | 0.00% | 0.0% |
Q2 2023 | $1,314,046 | -50.0% | 667,041 | -51.0% | 0.00% | -50.0% |
Q1 2023 | $2,628,391 | -6.2% | 1,361,860 | +2.1% | 0.00% | 0.0% |
Q4 2022 | $2,801,505 | -8.9% | 1,334,050 | -0.7% | 0.00% | 0.0% |
Q3 2022 | $3,076,000 | -19.4% | 1,343,467 | -0.4% | 0.00% | -33.3% |
Q2 2022 | $3,816,000 | -30.8% | 1,348,312 | +11.0% | 0.00% | 0.0% |
Q1 2022 | $5,515,000 | -44.6% | 1,214,725 | -0.9% | 0.00% | -50.0% |
Q4 2021 | $9,952,000 | -36.4% | 1,225,553 | -1.3% | 0.01% | -40.0% |
Q3 2021 | $15,653,000 | -19.8% | 1,241,322 | -1.7% | 0.01% | -23.1% |
Q2 2021 | $19,529,000 | – | 1,262,388 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Long Focus Capital Management, LLC | 4,487,293 | $7,089,923 | 0.25% |
OPPENHEIMER & CO INC | 121,420 | $191,844 | 0.00% |
CREDIT SUISSE AG/ | 1,438,255 | $2,272,443 | 0.00% |
Baillie Gifford | 1,164,009 | $1,839,135 | 0.00% |
PRINCIPAL FINANCIAL GROUP INC | 656,600 | $1,037,428 | 0.00% |
Capital International Investors | 1,848,804 | $2,921,110 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 1,095,966 | $1,731,626 | 0.00% |
EverSource Wealth Advisors, LLC | 13 | $21 | 0.00% |
Qube Research & Technologies Ltd | 40 | $63 | 0.00% |
Tower Research Capital LLC (TRC) | 111 | $175 | 0.00% |